Kouri T, Solakivi T, Harmoinen A
Tampereen Yliopistollinen Sairaala, Kliinisen kemaian yksikkö, Tampere, Finland.
Eur J Clin Chem Clin Biochem. 1994 May;32(5):419-23.
NycoCard:::U-Albumin and Micral-Test semiquantitative methods were evaluated against nephelometric measurements of nightly albumin excretion rates from 159 consecutive diabetic patients. Both methods can be safely applied for screening of intact renal function even at a strict prediction limit for incipient nephropathy of albumin excretion rate = 15 micrograms/min (standardised specimens collected at bed-rest), since the predictive values of negative tests were 95-100% for both tests. Predictive values of positive tests were 38% (NycoCard:::U-Albumin) and 44% (Micral-Test), if the designated value of 10 mg/l was used as the limit of positivity. By using 20 mg/l as the limit, the predictive values of positive tests were 62% (NycoCard:::U-Albumin) and 72% (Micral-Test), indicating the need for quantitative measurements in patients with positive screening results at both these limits.
针对159例连续糖尿病患者夜间白蛋白排泄率的散射比浊法测量结果,对NycoCard:::U -白蛋白和Micral - Test半定量方法进行了评估。即使在白蛋白排泄率 = 15微克/分钟(卧床休息时采集的标准化样本)这一早期肾病的严格预测限值下,这两种方法均可安全地用于完整肾功能的筛查,因为两种检测的阴性预测值均为95 - 100%。如果将指定的10毫克/升值用作阳性限值,则阳性检测的预测值分别为38%(NycoCard:::U -白蛋白)和44%(Micral - Test)。以20毫克/升作为限值时,阳性检测的预测值分别为62%(NycoCard:::U -白蛋白)和72%(Micral - Test),这表明对于在这两个限值下筛查结果为阳性的患者需要进行定量测量。